‘We don’t know’ what the limits are for RNA therapies
Cassel Salpeter Healthcare Industry Investment Bankers On mRNA Therapies
South Florida investment bank Cassel Salpeter managing directors consider future of mRNA Biotech
Author Archive for: roarmedia
Entries by
Trustee Makes Further Distribution in 1 Global Capital LLC, 1 West Capital LLC, Bankruptcy Cases
Miami Investment Banker Helps Creditors Receive Payment
Cassel Salpeter cofounder and chairman facilitates $6.9 million distribution to 3,750 creditors
Whether Fired or Tired, Young Guns Are Leaving Silicon Valley
Miami Investment Banker James Cassel Eyes Pressure on Unicorn Founders
Investment Banker James Cassel on Why Founders Leave After Their Companies Go Public
Q3 2022: Aviation Deal Report
Miami Investment Banking Firm Cassel Salpeter Issues Aviation Industry Deal Report
South Florida firm publishes Q3 2022 Aviation Deal Report surveying year’s company M&A, deal flow, and market trends
Q3 2022 Healthcare Update
Miami Investment Banking Firm Cassel Salpeter Releases Healthcare Industry Deal Report
South Florida firm publishes Q3 2022 Healthcare Deal Report surveying private placements, M&A, IPOs, public market activity, and trends
Q2 2022 Healthcare Update
South Florida firm publishes Q1 2022 Healthcare Deal Report surveying private placements, M&A, IPOs, public market activity, and trends
Moderna’s Second Act: is the Momentum Sustainable?
The potential for mRNA technology extends far beyond the COVID-19 vaccines that made it a household word.
